EB Research Partnership
  • Epidermolysis Bullosa
    • What is EB?
    • Resources
    • Life with EB
  • Research
    • Funded Projects
    • Consortia
    • Clinical Trials
    • Scientific Advisory Board
    • Apply for a Grant
    • Community Council
  • Get Involved
    • Donate
    • Venture Into Cures
    • Sponsor
    • EBRP Events >
      • ACTion for Jackson
      • All in for a Cure
    • Endurance Events
    • Community Led Events
  • Media
    • Press
    • Videos
  • About Us
    • Our Mission
    • Financials
    • Venture Philanthropy
    • Supporter Spotlight
    • Leadership >
      • Board of Directors
      • Staff
  • Donate

Funded Projects

EB Research Partnership reviews grant applications biannually, in January and July, and awards funding to competitive and innovative research projects with the potential to lead to commercially feasible products and therapies to treat and cure EB.
Picture
January 2019 Newly Funded Projects
​The table below covers newly awarded grants from our January 2019 grant cycle, totaling nearly $4.15M, that are funded in partnership with EB Research Foundation of Australia, EB Medical Research Foundation, and Cure EB.
INSTITUTION
PROJECT NAME
PRINCIPAL
INVESTIGATOR(S)
AMOUNT
AWARDED
​PolarityTE
Genetic modification of a commercially available Autologous Homologous Skin Construct for permanent epidermal replacement in Recessive Dystrophic Epidermolysis Bullosa
Nikolai Sopko MD PhD
​$300,000
​Columbia University
Development of a drug testing platform for recessive dystrophic epidermolysis bullosa squamous cell carcinoma using induced pluripotent cancer cells
Joanna Jackow PhD
$551,250
​Neem Biotech Limited
Identification of ajoene analogues for the treatment of epidermolysis bullosa
Tracy Nevitt PhD
​$112,400 
​Thomas Jefferson University
Targeting fibrosis for RDEB therapy in preclinical animal models
Andrew South PhD
$159,054
​University of Colorado
A Comprehensive Stem Cell Biobank for EB Patients
Ganna Bilousova PhD
Anna L. Bruckner MD
Dennis R Roop PhD
Igor Kogut PhD
$286,815
University of Minnesota
Next Generation Genome Editing for RDEB
Jakub Tolar MD PhD
$1,000,000
​University of Colorado
​A cGMP-Compliant Library Master Cell Bank as a Necessary Prerequisite for an iPSC-Based Clinical Trial for EB
​Igor Kogut PhD
Ganna Bilousova PhD
Dennis R Roop PhD
$964,176
​University of Colorado
Developing an iPS Cell-based Therapy for Epidermolysis Bullosa Simplex
Dennis R Roop PhD
Ganna Bilousova PhD
Igor Kogut PhD
Anna Bruckner MD
​$518,638
​Université du Québec à Chicoutimi
Inactivation of epidermolysis bullosa simplex dominant mutations by allele-specific CRISPR/Cas9
Catherine Laprise PhD
Lucie Germain PhD
Jacques-P Tremblay PhD
​$255,400
Wings Therapeutics
Clinical Development of QR-313 for Treatment of RDEB
Deborah Ramsdell
$1,500,000

EB Research Partnership

132 East 43rd St, Suite 432
New York, NY 10017
info@ebresearch.org
646-844-0902
Careers

Contact Us
​

Donor Privacy Policy
Donate

​
Our Mission

​
Press
  • Epidermolysis Bullosa
    • What is EB?
    • Resources
    • Life with EB
  • Research
    • Funded Projects
    • Consortia
    • Clinical Trials
    • Scientific Advisory Board
    • Apply for a Grant
    • Community Council
  • Get Involved
    • Donate
    • Venture Into Cures
    • Sponsor
    • EBRP Events >
      • ACTion for Jackson
      • All in for a Cure
    • Endurance Events
    • Community Led Events
  • Media
    • Press
    • Videos
  • About Us
    • Our Mission
    • Financials
    • Venture Philanthropy
    • Supporter Spotlight
    • Leadership >
      • Board of Directors
      • Staff
  • Donate